tradingkey.logo

Ekso Bionics Holdings Inc

EKSO
10.410USD
+1.050+11.22%
종가 02/06, 16:00ET시세는 15분 지연됩니다
27.31M시가총액
손실P/E TTM

Ekso Bionics Holdings Inc

10.410
+1.050+11.22%

자세한 내용은 Ekso Bionics Holdings Inc 회사

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Ekso Bionics Holdings Inc 정보

종목 코드 EKSO
회사 이름Ekso Bionics Holdings Inc
상장일Apr 10, 2013
CEODavis (Scott G)
직원 수61
유형Ordinary Share
회계 연도 종료Apr 10
주소101 Glacier Point
도시SAN RAFAEL
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94901
전화15109841761
웹사이트https://eksobionics.com/
종목 코드 EKSO
상장일Apr 10, 2013
CEODavis (Scott G)

Ekso Bionics Holdings Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+15747.00%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
18.59K
-1320.00%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.56K
-1238.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
+15747.00%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Relations
Investor Relations
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+15747.00%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
18.59K
-1320.00%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.56K
-1238.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
+15747.00%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
3.16M
74.78%
Other EMEA
428.00K
10.13%
France
363.00K
8.59%
APAC
253.00K
5.99%
Other Americas
22.00K
0.52%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Sun, Feb 1
마지막 업데이트: Sun, Feb 1
주주
주주 유형
주주
주주
비율
Asher (Daniel)
19.98%
Davis (Scott Gerald)
2.33%
Citadel Advisors LLC
1.14%
The Vanguard Group, Inc.
1.04%
Li (Kecheng)
0.91%
기타
74.61%
주주
주주
비율
Asher (Daniel)
19.98%
Davis (Scott Gerald)
2.33%
Citadel Advisors LLC
1.14%
The Vanguard Group, Inc.
1.04%
Li (Kecheng)
0.91%
기타
74.61%
주주 유형
주주
비율
Individual Investor
26.52%
Investment Advisor
1.86%
Hedge Fund
1.57%
Investment Advisor/Hedge Fund
0.97%
Research Firm
0.33%
Family Office
0.03%
기타
68.71%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
64
261.39K
8.72%
--
2025Q3
67
261.39K
11.41%
+205.54K
2025Q2
64
55.85K
14.40%
-195.55K
2025Q1
62
251.40K
15.39%
-37.98K
2024Q4
61
283.25K
26.99%
-87.09K
2024Q3
58
370.34K
18.68%
+159.85K
2024Q2
61
145.58K
14.28%
+25.92K
2024Q1
67
120.72K
11.67%
-18.52K
2023Q4
71
95.15K
14.09%
+2.45K
2023Q3
71
92.88K
16.51%
-13.62K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Davis (Scott Gerald)
78.95K
2.33%
+56.69K
+254.58%
Nov 10, 2025
Citadel Advisors LLC
38.55K
1.14%
+38.55K
--
Sep 30, 2025
The Vanguard Group, Inc.
35.45K
1.04%
+23.49K
+196.31%
Sep 30, 2025
Li (Kecheng)
30.73K
0.91%
+15.75K
+105.11%
May 16, 2025
Lathan (Corinna)
25.61K
0.75%
+15.75K
+159.61%
May 16, 2025
Cloyd (Mary Ann)
25.23K
0.74%
+15.75K
+166.00%
May 16, 2025
DRW Securities, LLC
20.19K
0.6%
+20.19K
--
Sep 30, 2025
Jones (Jason C)
19.91K
0.59%
-270.00
-1.34%
Dec 09, 2025
Cresset Asset Management, LLC
17.96K
0.53%
--
--
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
May 19, 2025
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
날짜
배당락일
유형
비율
May 19, 2025
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
KeyAI